Overweight - Early stage of "adipokines related cardiovascular diseases": Leptin and adiponectin relation to anthropometric parametars;Prekomjerna tjelesna težina - rani stadij "kardiovaskularnih bolesti povezanih s adipokinima": Odnos adiponektina i leptina s antropometrijskim parametrima

Medicinski Glasnik

Volumn 9, Issue 2, 2012, Pages 198-203

  Selthofer Relatić, Kristina ^a,b   Divković, Dalibor ^b   Radić, Radivoje ^b   Vizjak, Vedrana ^a   Selthofer, Robert ^a   Steiner, Robert ^a   Bošnjak, Ivica ^a  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

Body mass index; Hypertension; Ischemic heart disease; Obesity; Waist circumference; Waist to hip ratio

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CREATININE; GLUCOSE; LEPTIN;

ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; OBESITY; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADULT; BLOOD; BODY SIZE;

ADIPONECTIN; ADULT; BODY MASS INDEX; BODY SIZE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LEPTIN; MALE; OVERWEIGHT; WAIST CIRCUMFERENCE;

EID: 84868246751     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord 2001; 25: 1047-56.
2. Karakas M, Zierer A, Hereder C, Baumert J, Meisinger C, Koenig W, Thorand B. Leptin, adiponectin, their ratio, and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 2010; 209:220-5.
3. Wang Y, Rimm EB, Stampfer MJ, Willet WC, Hu FB. Comparision of abdominal and overall obesity in predictin risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81:555-63.
4. Despres JP, Lemieux I. Abdominal obesity and the metabolic syndrome. Nature 2006; 444:881-7.
5. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular disease. Eur Heart J 2008; 29:2959-71.
6. Lakka HM, Lakka TA, Tuomileheto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002; 23: 706-13.
7. Carr DB, Utzschneider KM, Hul RL, Kodama K, Rezlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53:2087-94.
8. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence of independent roles of age and sex. Diabetologia 2003; 46:459-69.
9. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin an the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104:3052-56.
10. Azizi F, Esmaillzadeh A, Mirmirn P, Ainy E. Is there an independent association waist-to-hip ratio and cardiovascular risk factors in overweight and obese woman? Int J Cardiol 2005; 101:39-46.
11. Authors/Task Force Members: Giuseppe Mancia, Co-Chairpersona, Guy De Backer, Co-Chairpersonb, Anna Dominiczakc, Renata Cifkovad, Robert Fagarde, Giuseppe Germanof, Guido Grassig, Anthony M. Heagertyh, Sverre E. Kjeldseni, Stephane Laurentj, Krzysztof Narkiewiczk, Luis Ruilopel, Andrzej Rynkiewiczm, Roland E. Schmiedern, Harry A.J. Struijker Boudiero, Alberto Zanchettip. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension. J Hypertens 2007; 25:1751-62.
12. World health organisation. Obesity. http://www.who. int/topics/obesity/en/
13. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010; 17:4511-20.
14. Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev 2007; 8:3-10.
15. Feldstein CA, Akopian M, Olivieri AO, Kramer AP, Nasi M, Garrido D. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study. Nutr Metab Cardiovasc Dis 2005; 15: 310-5.
16. Hajer GR, van Haeften TW, Vissereb FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29:2959-71.
17. Younus S, Rodgers G. Biomarkers associated with cardiometabolic risk in obesity. Am J Heart Hosp J 2011; 9:28-32.
18. Selthofer-Relatić K, Radić R, Vizjak V, Vcev A, Kosović P, Bosnjak I, Selthofer R. Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females. Coll Antropoll 2008; 32:681-5.
19. Selthofer-Relatić K, Radić R, Včev A, Steiner R, Vizjak V, Šram M, Tripolski M, Kosović P, Bošnjak I, Selthofer R. Low adiponectin serum level-reduced protective effect on the left ventricular wall thickness: Coll Antropoll 2011; 35:787-91.
20. Akipnar E, Bashan I, Bozdemir N, Saatci E. Which is the best anthropometric technique to identify obesity: body mass index, waist circumference or waisthip ratio? Coll Antrpol 2007; 31:378-93.
21. Guzik TJ, Mangalat D, Korbut R. Adipocytokinesnovel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57:505-28.
22. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004; 13:215-23.
23. Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertens 2008; 51:8-14.
24. Radić R, Nikolić V, Karner I, Kurbel S, Selthofer R. Ultrasound measurement in defining the regional distribution of subcutaneous fat tissue. Coll Antropol 2002; 26:59-68.
25. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National health and nutrition federation surveys, 1960 to 1961. JAMA 1994; 272:205-11.
26. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ 1998; 317:319.
27. Smith J, Al-Amri M, Sniderman A, Cianflone K. Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB7apoA I ratio in Asian Indian and Caucasian men and woman. Nutr Metab 2006; 10:3-18.
28. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010; 535-918
29. De Konig L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip artio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28:850-56.
30. Mota JF, Rinaldi AE, Pereira AF, Orsatti FL, Burini RC. Anthropometric indicators as risk markers for metabolic abnormalities. Cien Saude Colet 2011; 16: 3901-8.
31. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967:379-88.
32. Mattsson C, Olsson T. Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 2007; 14:2918-24.